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It is believed that inotropic agents exert their effects in cardiac muscle via a modulation of Ca'+ cycling; however, the involvement of phospholipase activation and the biochemical pathways participating in inotropic responsiveness remain unclear. It is widely accepted that inotropic agents exert some of their effects on the cardiac muscle cell via modulation of Ca2' release from the sarcoplasmic reticulum (SR). However, with the exception of ,B-adrenergic agonists, the mechanisms and mediators of this release remain unclear. Inotropic stimulation of cardiac muscle by a-adrenergic agonists angiotensin II, bradykinin, or endothelin results in phospholipase C-dependent release of inositol trisphosphate and diacylglycerol from phosphatidylinositol bisphosphate. Diacylglycerol is known to activate protein kinase C (PKC),' and inositol trisphosphate has been shown to be involved in agonist-induced release of Ca2+ from SR in smooth muscle2 and nonmuscle cells.3 However, evidence of a role for inositol trisphosphate in triggering Ca2' release from the SR in cardiac muscle is controversial.4-6 Therefore, alternative second messenger systems may be involved in mediating the response to inotropic agents in the heart. In recent years, considerable evidence has accumulated to suggest a significant role for arachidonic acid (AA) and its oxidized metabolites in signal transduction processes.7-9 The agonist-induced release of AA from the sn-2 position of membrane glycerophospholipids may proceed via activation of phospholipase A2 or the sequential actions of phospholipase C and diacylglycerol lipases. The release of AA is physiologically relevant, since AA is the rate-limiting precursor of a group of biologically active compounds (eicosanoids) derived via cyclooxygenase (CO), lipoxygenase (LO), or epoxygenase (EO) pathways and AA itself, as well as the eicosanoids, have been implicated as second messengers. 7, 10 Previous studies exploring a physiological role for AA in cardiac muscle have been overshadowed by the overwhelming interest in the pathophysiological effects of AA associated with irreversible myocardial ischemia. Recent studies in cardiac muscle, however, have implicated phospholipase A2 activation and AA metabolites in physiological signal transduction processes. It is known that stimulation by angiotensin II and bradykinin results in release of AA and AA metabolites in perfused rabbit hearts and kidneys'1 in addition to the more established activation of phospholipase C-dependent pathways. Endothelin has been shown to stimulate the degradation of phospholipids and accumulation of AA in perfused rabbit hearts12 as well as the accumulation of AA metabolites in vascular smooth muscle cells. 13 release from the SR.
Materials and Methods Myocyte Preparation
Ventricular myocytes were prepared from the hearts of 250-400-g adult Sprague-Dawley rats according to a modification of the procedure of Altschuld et al. 21 Briefly, the heart was removed, cannulated via the aorta, mounted on a modified Langendorff perfusion apparatus, and perfused (10 ml/min) for 5 minutes at 37°C with oxygenated (95% 02-5% C02) Krebs-Henseleit buffer containing (mM) NaCl 118, KCl 4.8, MgCl2 1.2, KH2PO4 1.2, CaCI2 1.2, NaHCO3 25, dextrose 11, and pyruvate 5 supplemented with 0.68 mM glutamine, 0.1 mM minimum essential medium, and basal medium Eagle amino acids and vitamin solutions, pH 7.35. The heart was then perfused with the same buffer, but lacking Ca2' and containing 30 ,uM EGTA (Ca2+-free Krebs-Henseleit buffer), for 14 minutes. Collagenase type 11 (237 units/ml) plus 0.1% bovine serum albumin was then added to the perfusate and allowed to circulate for 20 minutes. Protease (0.4 units/ml, type XIV) was added, and aliquots of 0.1 M CaCl2 were added at 5-minute intervals to a final concentration of 1.2 mM CaCl2. After 45-50 minutes of collagenase digestion, the heart was removed from the perfusion apparatus and dissected, and the ventricles were minced and shaken in Krebs-Henseleit buffer containing collagenase (237 units/ml) for 10 minutes under 95% 02-CO2 at 37°C. After two brief triturations at 5-minute intervals, the digest was filtered over cheesecloth and sedimented at 75g for 2 minutes. The resulting pellet was washed with oxygenated Krebs-Henseleit buffer (NaHCO3 replaced with 25 mM HEPES) supplemented with 0.5% bovine serum albumin, pH 7.35, and allowed to settle at room temperature for 10 minutes. The pellet was further purified by a second wash in the same buffer supplemented with 4% bovine serum albumin for 10 minutes. The final pellet was resuspended in the same buffer and maintained at room temperature throughout the remainder of the experiment. Cell viability, as determined by the percentage of cells retaining a rodshaped form, was 75-90%. Only a 10-15% loss of viability was observed in the cell population over a 5-hour period. Yields were typically 5-7x106 rodshaped cells per heart.
Intracellular Ca2+ Measurements
Fura-2 loading procedure. The myocytes were gently shaken in Krebs-Henseleit buffer containing 4 ,uM fura-2 AM at 23°C for 30 minutes. After the 30-minute loading period, myocytes were centrifuged at 75g for 2 minutes, and the resulting pellet was washed in KrebsHenseleit buffer containing 4% bovine serum albumin and allowed to settle for 10 minutes on the bench. The supernatant was then aspirated, and the pellet was resuspended in Krebs-Henseleit buffer at a concentration of 1 x 106 cells/ml.
Fluorescence measurements. Fluorescence measurements were carried out using 2-ml cell suspensions (150,000 cells per cuvette) under constant stirring and temperature (37°C) in a custom-built fluorometer specifically designed for single-excitation wavelength measurements in cell suspensions (University of Pennsylvania Biomedical Instrumentation Group, Philadelphia, Pa.). A 75-W xenon lamp (UVP Inc., San Gabriel, Calif.) was the excitation source. The excitation wavelength was filtered with a 340-nm filter, and the emitted light was collected 900 from the excitation source through a 510-nm filter. The time course of changes in the fura-2 signal was recorded on a dual-pen strip-chart recorder (Linseis Inc., Princeton Junction, N.J.) at two different sensitivities.
In some experiments, myocytes were stimulated electrically (S44 stimulator, Grass Instrument Co., Quincy, Mass.) through platinum wire electrodes with 30-V field stimulation in the cuvette at a frequency of 0.15 Hz and a duration of 5 msec.
Fura-2 Calibration Procedure
Fura-2 signals were calibrated as previously described. 22 Briefly, the myocytes were lysed by adding digitonin (4 ,uM) to the cell suspension medium (containing 1.2 mM CaCl2) to obtain the maximum fluorescence (F.n,) of fura-2 when bound to a saturating Ca21 concentration. Once the fluorescence signal, after the addition of digitonin, had stabilized, 7 mM EGTA plus for Ca2`is taken as 224 nM, as described by Grynkiewicz et al. 22 There was no evidence of cell autofluorescence, since no increase in basal fluorescence was observed upon addition of myocytes not loaded with fura-2 to the cuvette. The fluorescence of any extracellular fura-2 that may have leaked from the cells was subtracted from the basal fluorescence of fura-2 in intact cells by subtracting the decrease in fluorescence induced by addition of 7 mM EGTA, pH 8 the LO inhibitor nordihydroguaiaretic acid (NDGA, 1-5 gM) had no effect on the AA-induced enhancement of the ATP-stimulated Ca2+ transient, whereas higher concentrations of NDGA (>10 gM) inhibited Figure 5B ). These concentrations of staurosporine and sphingosine had no effect on the ATP-stimulated Ca' transient in the absence of AA ( Figure 5A) (Figure 6 ), this effect could also be (Figure 3) suggest that AA has the ability to stimuIate Ca' release from an intracellular store and that this is largely independent of Ca>2 influx across the sarcolemma. Furthermore, a significant reduction in the Ca 2+ transient after caffeine pretreatment suggests that AA has the ability to stimulate the release of Ca 2+ from the SR, since caffeine is known to deplete the SR store of Ca2+.30 These results would be consistent with the idea that direct or indirect activation of phospholipase A2, which can release AA from membrane phospholipids, may mediate the actions of inotropic agonists, such as endothelin, bradykinin, angiotensin II, or a-adrenergic agonists.
Effect of Fatty Acids on Ca2+ Transients Induced by Extracellular ATP in Quiescent Myocytes
Pretreatment of cardiac myocytes with saturated, monounsaturated, or trans-configured unsaturated fatty acids had no effect on the ATP-evoked transient in- (Table 1) .
The common denominator among effective PUFAs was possession of the cis-1,4-pentadiene configuration. All of the other fatty acids tested were not substrates for enzymatic oxidation via the CO, LO, or EO pathways. In addition, the suicide substrate ETYA, which is structurally similar to AA but not a known activator of PKC, failed to mimic the actions of AA, LA, and DHA on the ATP-induced Ca'2 transients (Figure 4) (Figure 7 ) and by ETYA. Therefore, it appears that PUFAs have the ability to insert themselves into the sarcolemmal membrane and either directly or indirectly alter the permeability properties of ion channels. The results would be consistent with the activation of K' channels as previously described,36 since an increase in the amplitude of the K' current would shorten the action potential duration and this could result in a decrease in Ca2+ influx during the action potential plateau. The physiological relevance of these results lies in the elucidation of the intracellular signaling mechanisms by which certain agents such as endothelin, bradykinin, and a-adrenergic agonists may exert their inotropic effects in cardiac muscle. It is known that these compounds stimulate the release of unesterified AA from membrane phospholipids39,40; however, the role of AA or AA metabolites in excitation-contraction coupling events in cardiac muscle has remained obscure. It is possible that the activation of phospholipase A2 is a critical step leading to the release of AA, which in turn modulates intracellular Ca2' availability for myofilament activation, thereby imparting some control over excitation-contraction coupling events in cardiac muscle.
